|
PSMC6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.897100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.036800E-01 |
| Normal-vs-Stage2 |
7.701600E-02 |
| Normal-vs-Stage3 |
7.53320000000945E-05 |
| Normal-vs-Stage4 |
3.958000E-02 |
| Stage1-vs-Stage2 |
2.137000E-01 |
| Stage1-vs-Stage3 |
4.765300E-04 |
| Stage1-vs-Stage4 |
1.601370E-01 |
| Stage2-vs-Stage3 |
2.500600E-01 |
| Stage2-vs-Stage4 |
8.277200E-01 |
| Stage3-vs-Stage4 |
3.813400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.759000E-03 |
| Normal-vs-AfricanAmerican |
3.920000E-02 |
| Normal-vs-Asian |
7.215400E-01 |
| Caucasian-vs-AfricanAmerican |
8.172400E-01 |
| Caucasian-vs-Asian |
6.428000E-01 |
| AfricanAmerican-vs-Asian |
5.242400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.515900E-03 |
| Normal-vs-Female |
3.839700E-02 |
| Male-vs-Female |
4.042600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.863980E-02 |
| Normal-vs-Age(41-60Yrs) |
8.176300E-02 |
| Normal-vs-Age(61-80Yrs) |
8.246300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.665980E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.142400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.371800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.106400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.852990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.722000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.217400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.076100E-02 |
| Normal-vs-Grade 2 |
3.799200E-01 |
| Normal-vs-Grade 3 |
3.228400E-04 |
| Normal-vs-Grade 4 |
3.172600E-04 |
| Grade 1-vs-Grade 2 |
1.004950E-01 |
| Grade 1-vs-Grade 3 |
7.277400E-03 |
| Grade 1-vs-Grade 4 |
8.2722000000035E-05 |
| Grade 2-vs-Grade 3 |
3.379600E-03 |
| Grade 2-vs-Grade 4 |
1.415610E-03 |
| Grade 3-vs-Grade 4 |
1.083000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.655400E-01 |
| Normal-vs-ccB subtype |
3.76889999997854E-06 |
| ccA subtype-vs-ccB subtype |
1.67340000001293E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.853700E-02 |
| Normal-vs-N1 |
2.2383999997988E-07 |
| N0-vs-N1 |
1.120640E-03 |
|
|
